Christopher B. Eiben

1.1k total citations · 1 hit paper
11 papers, 731 citations indexed

About

Christopher B. Eiben is a scholar working on Molecular Biology, Biomedical Engineering and Pharmacology. According to data from OpenAlex, Christopher B. Eiben has authored 11 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Biomedical Engineering and 2 papers in Pharmacology. Recurrent topics in Christopher B. Eiben's work include Microbial Metabolic Engineering and Bioproduction (6 papers), Genomics and Phylogenetic Studies (3 papers) and Enzyme Catalysis and Immobilization (3 papers). Christopher B. Eiben is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (6 papers), Genomics and Phylogenetic Studies (3 papers) and Enzyme Catalysis and Immobilization (3 papers). Christopher B. Eiben collaborates with scholars based in United States, Denmark and China. Christopher B. Eiben's co-authors include Jacob B. Bale, Jay D. Keasling, Barry Stoddard, Betty Shen, Justin B. Siegel, David Baker, Zoran Popović, Foldit Players, Seth Cooper and Firas Khatib and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Christopher B. Eiben

10 papers receiving 711 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Computational protein design enables a novel one-carbon assimilation pathway

2015 315 citations Justin B. Siegel, Sean Poust et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Christopher B. Eiben

Since Specialization

Citations

This map shows the geographic impact of Christopher B. Eiben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Eiben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Eiben more than expected).

Fields of papers citing papers by Christopher B. Eiben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher B. Eiben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Eiben. The network helps show where Christopher B. Eiben may publish in the future.

Co-authorship network of co-authors of Christopher B. Eiben

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher B. Eiben. A scholar is included among the top collaborators of Christopher B. Eiben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher B. Eiben. Christopher B. Eiben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Fatty Acid and Alcohol Metabolism in Pseudomonas putida: Functional Analysis Using Random Barcode Transposon Sequencing (vol 86, e01665-20, 2020) 2021 ·Applied and Environmental Microbiology ·(unknown), Matthew R. Incha, Allison N. Pearson, Matthias Schmidt, (unknown), Christopher B. Eiben, (unknown), Jacquelyn M. Blake-Hedges, Yuzhong Liu, Catharine A. Adams, Robert W. Haushalter, (unknown), (unknown), Lars M. Blank, Aindrila Mukhopadhyay, Adam M. Deutschbauer, Patrick M. Shih, Jay D. Keasling	0
2	Lepidopteran mevalonate pathway optimization in Escherichia coli efficiently produces isoprenol analogs for next-generation biofuels 2021 ·Metabolic Engineering ·Bo Pang, Jia Li, Christopher B. Eiben, (unknown), Carolina A. Barcelos, Rong Chen, Elias Englund, Eric Sundström, Jay D. Keasling	12
3	Correction for Thompson et al., “Fatty Acid and Alcohol Metabolism in Pseudomonas putida: Functional Analysis Using Random Barcode Transposon Sequencing” 2021 ·Applied and Environmental Microbiology ·(unknown), Matthew R. Incha, Allison N. Pearson, Matthias Schmidt, (unknown), Christopher B. Eiben, (unknown), Jacquelyn M. Blake-Hedges, Yuzhong Liu, Catharine A. Adams, Robert W. Haushalter, (unknown), (unknown), Lars M. Blank, Aindrila Mukhopadhyay, Adam M. Deutschbauer, Patrick M. Shih, Jay D. Keasling	2
4	Fatty Acid and Alcohol Metabolism in Pseudomonas putida: Functional Analysis Using Random Barcode Transposon Sequencing 2020 ·Applied and Environmental Microbiology ·(unknown), Matthew R. Incha, Allison N. Pearson, Matthias Schmidt, (unknown), Christopher B. Eiben, Pablo Cruz‐Morales, Jacquelyn M. Blake-Hedges, Yuzhong Liu, Catharine A. Adams, Robert W. Haushalter, (unknown), (unknown), Lars M. Blank, Aindrila Mukhopadhyay, Adam M. Deutschbauer, Patrick M. Shih, Jay D. Keasling	66
5	Adenosine Triphosphate and Carbon Efficient Route to Second Generation Biofuel Isopentanol 2020 ·ACS Synthetic Biology ·Christopher B. Eiben, Tian Tian, (unknown), Daniel Mendez‐Perez, (unknown), Garima Goyal, Jennifer Chiniquy, Nathan J. Hillson, Taek Soon Lee, Jay D. Keasling	9
6	Massively Parallel Fitness Profiling Reveals Multiple Novel Enzymes in Pseudomonas putida Lysine Metabolism 2019 ·mBio ·Mitchell G. Thompson, Jacquelyn M. Blake-Hedges, Pablo Cruz‐Morales, Jesus F. Barajas, S.C. Curran, Christopher B. Eiben, Nicholas C. Harris, Veronica T. Benites, Jennifer Gin, (unknown), (unknown), (unknown), (unknown), J.H. Pereira, Edward E. K. Baidoo, Christopher J. Petzold, Paul D. Adams, Adam P. Arkin, Adam M. Deutschbauer, Jay D. Keasling	47
7	Mevalonate Pathway Promiscuity Enables Noncanonical Terpene Production 2019 ·ACS Synthetic Biology ·Christopher B. Eiben, Tristan de Rond, (unknown), Jennifer Gin, Jennifer Chiniquy, Edward E. K. Baidoo, Christopher J. Petzold, Nathan J. Hillson, Oliver Fiehn, Jay D. Keasling	28
8	Leveraging microbial biosynthetic pathways for the generation of ‘drop-in’ biofuels 2017 ·Current Opinion in Biotechnology ·Amin Zargar, Constance B. Bailey, Robert W. Haushalter, Christopher B. Eiben, Leonard Katz, Jay D. Keasling	49
9	Computational protein design enables a novel one-carbon assimilation pathway breakdown → 2015 ·Proceedings of the National Academy of Sciences ·Justin B. Siegel, (unknown), Sean Poust, Adam J. Wargacki, Arren Bar‐Even, (unknown), Betty Shen, Christopher B. Eiben, Huu M. Tran, Εlad Noor, Jasmine L. Gallaher, Jacob B. Bale, Yasuo Yoshikuni, Michael H. Gelb, Jay D. Keasling, Barry Stoddard, Mary E. Lidstrom, David Baker	315
10	Increased Diels-Alderase activity through backbone remodeling guided by Foldit players 2012 ·Nature Biotechnology ·Christopher B. Eiben, Justin B. Siegel, Jacob B. Bale, Seth Cooper, Firas Khatib, Betty Shen, Foldit Players, Barry Stoddard, Zoran Popović, David Baker	193
11	Improvement of a Potential Anthrax Therapeutic by Computational Protein Design 2011 ·Journal of Biological Chemistry ·(unknown), Christopher B. Eiben, John H. Carra, Ivan Huang, David M. Zong, (unknown), (unknown), Jeff Nivala, (unknown), (unknown), (unknown), (unknown), Matthew D. Smith, Jeremy H. Mills, Arthur M. Friedlander, David Baker, Justin B. Siegel	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact